Switch theme
Sign up to access all valuation multiples
Cawachi Ltd is a drug store operator based in Japan. The firm primarily sells pharmaceutical-related products to its customers. It also sells health foods, child care products, cosmetics, grocery, general food and confectionery through its retail outlets. The company operates over 300 stores across Japan.
1980
6.7K+
LTM Revenue $2.0B
Last FY EBITDA $78.9M
$278M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cawachi has a last 12-month revenue (LTM) of $2.0B and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Cawachi achieved revenue of $2.0B and an EBITDA of $78.9M.
Cawachi expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cawachi valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| Gross Profit | $2.0B | XXX | $452M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | $78.9M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 4% | XXX | XXX | XXX |
| EBIT | $51.2M | XXX | $52.2M | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $33.5M | XXX | $32.3M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cawachi's stock price is JPY 2813 (or $19).
Cawachi has current market cap of JPY 62.8B (or $431M), and EV of JPY 40.5B (or $278M).
See Cawachi trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $278M | $431M | XXX | XXX | XXX | XXX | $1.50 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cawachi has market cap of $431M and EV of $278M.
Cawachi's trades at 0.1x EV/Revenue multiple, and 3.6x EV/EBITDA.
Equity research analysts estimate Cawachi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cawachi has a P/E ratio of 12.9x.
See valuation multiples for Cawachi and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $431M | XXX | $431M | XXX | XXX | XXX |
| EV (current) | $278M | XXX | $278M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 3.6x | XXX | XXX | XXX |
| EV/EBIT | 5.4x | XXX | 5.5x | XXX | XXX | XXX |
| EV/Gross Profit | 0.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 12.9x | XXX | 13.7x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 22.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCawachi's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Cawachi's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cawachi's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cawachi and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cawachi acquired XXX companies to date.
Last acquisition by Cawachi was XXXXXXXX, XXXXX XXXXX XXXXXX . Cawachi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cawachi founded? | Cawachi was founded in 1980. |
| Where is Cawachi headquartered? | Cawachi is headquartered in Japan. |
| How many employees does Cawachi have? | As of today, Cawachi has 6.7K+ employees. |
| Is Cawachi publicy listed? | Yes, Cawachi is a public company listed on TKS. |
| What is the stock symbol of Cawachi? | Cawachi trades under 2664 ticker. |
| When did Cawachi go public? | Cawachi went public in 2002. |
| Who are competitors of Cawachi? | Similar companies to Cawachi include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of Cawachi? | Cawachi's current market cap is $431M |
| What is the current revenue of Cawachi? | Cawachi's last 12 months revenue is $2.0B. |
| What is the current EV/Revenue multiple of Cawachi? | Current revenue multiple of Cawachi is 0.1x. |
| Is Cawachi profitable? | Yes, Cawachi is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
